SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

GE HealthCare Technologies Inc

GE HealthCare is seeing increased discussion following its Q4 earnings beat and raised future guidance, which is largely reassuring investors about its strategic advancements in AI-driven medical imaging and cloud solutions, though contrasting analyst opinions and community frustrations over past performance add nuance to the conversation.

Frontier Group Holdings, Inc. engages in the provision of air transportation. The company was founded on July 5, 1994 and is headquartered in Denver, CO.

Frontier Group Holdings Inc

Frontier Group is trending as rival Spirit Airlines' second bankruptcy filing sparks community speculation about ULCC capturing increased market share and reducing competition in the ultra-low-cost sector. Despite recent management changes, many investors view ULCC as undervalued and poised for a rally, driven by anticipated strong summer travel demand and favorable oil price trends.

James Hardie Industries Plc engages in the provision of fiber cement and fiber gypsum building solutions. It operates through the following segments: North America Fiber Cement, Asia Pacific Fiber Cement, Europe Building Products, and Research and Development. The North America Fiber Cement segment manufactures fiber cement interior linings, exterior siding products, and related accessories in the United States; these products are sold in the United States and Canada. The Asia Pacific Fiber Cement segment includes all fiber cement products manufactured in Australia and the Philippines, and sold in Australia, New Zealand, Asia, the Middle East and Pacific Islands. The Europe Building Products segment encompasses the Fermacell business and fiber cement product manufactured in the United States that is sold in Europe. The Research and Development segment represents the cost incurred by the research and development centers. The company was founded in 1888 and is headquartered in Dublin, Ireland.

James Hardie Industries plc

James Hardie Industries SE

James Hardie Industries is trending after its strong Q2 earnings report and upgraded guidance sparked significant bullish sentiment. The community is actively discussing the company's demand resilience, pricing power, and potential for further growth within the housing and building materials sector.

Sportradar Group AG engages in the provision of sports betting and entertainment products and services. Its products include Betting Technology & Solutions and Sports Content, Technology & Services. The company was founded by Carsten Marcus Koerl in 2001 and is headquartered in St. Gallen, Switzerland.

Sportradar Group AG - Ordinary Shares - Class A

Sportradar (SRAD) is trending as investors weigh concerns from a critical report regarding competition and business practices against its recent strategic acquisition of IMG ARENA and ongoing growth in the sports data sector. Community discussion is focused on the evolving landscape of prediction markets and their potential impact on SRAD's established "picks and shovels" model.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is trending as investors actively "buy the dip" following recent selling pressure, partly fueled by a critical article, with many highlighting its resilient monthly dividend and discounted reinvestment program as compelling amidst broader expectations of future rate cuts.

Axelar delivers secure interchain communication. That means dApp users can interact with any asset, any application, on any chain, with one click. You can think of it as Stripe for Web3. Developers interact with a simple API atop a permissionless network that routes messages and ensures network security via proof-of-stake consensus.  Axelar is a blockchain that connects blockchains. To do this securely, Axelar network uses proof-of-stake consensus. Network validators produce new blocks, participate in multiparty signing and vote on external chain states. Tokenholders stake the AXL token, delegating tokens to a validator’s staking pool and receiving rewards, minus the validator’s commission.  The AXL token is used for governance and to pay network transaction fees to validators and tokenholders. However, users of the Axelar network do not need to hold the token. Conversions into AXL tokens and destination-chain tokens are handled on the back end, so that users need only pay gas once, in the source-chain token.  Axelar network rewards are “inflationary” — they increase the total supply of AXL — but there is potential for supply to become deflationary based on the transaction fee mechanic described above.

Axelar

Axelar is experiencing a volatile trend driven by community division over the recent acquisition of its original developer team by Circle, sparking fears of an "empty shell" while many "buy the dip." Bullish investors highlight Axelar's critical role in newly launched initiatives like mXRP liquid staking for the XRP Ledger and strategic institutional partnerships for tokenized Real World Assets, arguing its core interoperability services remain undervalued.

SM Energy Co. is an independent energy company, which engages in the provision of acquisition, exploration, development, and production of oil, gas, and natural gas liquids. The company was founded in 1908 and is headquartered in Denver, CO.

SM Energy Co

SM Energy is trending as the community eagerly re-evaluates its significantly undervalued position following the Civitas Resources merger, highlighting robust combined fundamentals and synergies that suggest a substantial re-rating compared to peers.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is trending following its "transformational" acquisition of Legend for up to $1.2 billion, a move that has sparked widespread community skepticism over its valuation, increased debt, and dilution, challenging prior market optimism for the sports data and media giant.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is trending amid high community speculation around its AI agent utility on the Base chain, with discussions highlighting its recent expansion to Solana, increasing exchange listings, and strong holder conviction for substantial future growth.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies Inc

Voyager Technologies is trending amid widespread community discussion regarding its Starlab space station as a frontrunner for upcoming NASA Commercial LEO Destinations awards, complemented by recent strategic acquisitions and defense contract activity that solidifies its role in the booming space and national security sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Nuveen ESG Small-Cap ETF (NUSC) a Strong ETF Right Now?

<ul class="summary-bullets"><li>The FDA feedback indicates the company can establish&nbsp;substantial evidence of effectiveness without conducting additional&nbsp;hidradenitis suppurativa trials.</li><li>The firm remains on track to submit its Biologic License Application for Sonelokimab in the second half of 2026.</li><li>MoonLake will host an Investor Day on February 23 to review FDA feedback from the Type B meeting.</li></ul>Shares of MoonLake Immunotherapeutics (MLTX) surged 45% in premarket trading on Thursday after the company said it received positive regulatory feedback from the U.S. Food and Drug Administration (FDA) following a Type B meeting regarding Sonelokimab (SLK), a drug used to treat hidradenitis suppurativa (HS), a chronic inflammatory skin disorder.The FDA feedback indicates the company can establish substantial evidence of effectiveness (SEE) without conducting additional HS trials, using a Biologic License Application (BLA) supported by data from its existing VELA-1, VELA-2, and MIRA studies.The agency advised including MIRA results to support efficacy and submitting VELA-2 data to inform the safety profile. Based on the official meeting outcome, the company remains on track to submit its BLA for Sonelokimab in the second half of 2026.“The positive outcome of our Type B meeting with the FDA provides the clarity needed to support a pathway to approval for our existing HS program, with no additional clinical trials required. In addition, the fact that we can prepare the BLA with the wealth of data across the VELA and MIRA trials provides us and the FDA with flexibility to determine the best label possible, so that SLK, if approved, can have the most positive impact for HS patients,” said Jorge Santos da Silva, Founder and Chief Executive Officer at MoonLake Immunotherapeutics.<h2 class="st-heading-2">2026 Pipeline</h2>MoonLake will host an Investor Day on Feb. 23, 2026, to review the FDA feedback from the Type B meeting and share new clinical data for SLK across indications, along with updates to its 2026 catalyst outlook.The company also expects a steady flow of clinical readouts over the next year, including Phase 2 data in axial spondyloarthritis and multiple Phase 3 updates in psoriatic arthritis and HS. Key milestones include a Phase 2 axSpA readout in Q1 2026, several Phase 3 readouts by mid-2026, and a planned BLA submission in the second half of 2026.<h2 class="st-heading-2">How Did Stockwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘high’ message volumes. <a href="https://stocktwits.com/symbol/MLTX">MLTX</a> was among the top trending stocks on the platform at the time of writing.<figure class="image"><img src="https://news.stocktwits-cdn.com/MLTX_jpg_70c33bd6fe.webp" alt="MLTX.jpg" width="916" height="96"><figcaption>MLTX's Sentiment Meter and Message Volumes at Premarket on Jan. 8, 2026 | Source: Stocktwits</figcaption></figure>One user expects the stock to climb to $22 within a few sessions. It is currently trading at $16.2.<stembedurl>https://stocktwits.com/discountcroesus1/message/641193716</stembedurl>The stock has been under heavy selling pressure over the past year, declining nearly 80%.Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/why-vnda-stock-falling-premarket/cmUbEA9R4Pn">Vanda Stock Drops 10% Premarket After FDA Rejects Jet Lag Drug Application</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a MoonLake Immunotherapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Why Did MLTX Stock Jump 45% In Pre-Market Today?

The company said it received positive regulatory feedback from the U.S. FDA following a Type B meeting regarding a drug used to treat hidradenitis suppurativa, a chronic inflammatory skin disorder.

Equity

Nuveen Fund Advisors LLC - Nuveen ESG Small-Cap ETF

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$48.31
Prev Close	$46.92
Open	$47.50
Dividend Yield	N/A
50-Day Moving Average	$46.23
Beta	N/A
Avg. Volume	206,225.35
PE Ratio	N/A

52-Week High	$48.58
52-Week Low	$32.87
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

NUSC
Nuveen Fund Advisors LLC - Nuveen ESG Small-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest NUSC News

NUSCNuveen Fund Advisors LLC - Nuveen ESG Small-Cap ETF